Resistance to octreotide LAR in acromegalic patients with high SSTR2 expression: analysis of AIP expression

AIP expression in sporadic somatotropinomas is a predictor of the response to octreotide LAR therapy independent of SSTR2 expression

(2012) Leandro Kasuki et al.   ENDOCRINE-RELATED CANCER

Germline AIP Mutations in Apparently Sporadic Pituitary Adenomas: Prevalence in a Prospective Single-Center Cohort of 443 Patients

(2012) Laure Cazabat et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Somatostatin Analogs Modulate AIP in Somatotroph Adenomas: The Role of the ZAC1 Pathway

(2012) Harvinder S. Chahal et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Familial isolated pituitary adenomas experience at a single center: clinical importance of AIP mutation screening

(2011) Leandro Kasuki Jomori de Pinho et al.   Arquivos Brasileiros de Endocrinologia e Metabologia

Recomendações do Departamento de Neuroendocrinologia da Sociedade Brasileira de Endocrinologia e Metabologia para o diagnóstico e tratamento da acromegalia no Brasil

(2011) Leonardo Vieira Neto et al.   Arquivos Brasileiros de Endocrinologia e Metabologia

Clinical Characteristics and Therapeutic Responses in Patients with Germ-LineAIPMutations and Pituitary Adenomas: An International Collaborative Study

(2010) Adrian F. Daly et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Low Aryl Hydrocarbon Receptor-Interacting Protein Expression Is a Better Marker of Invasiveness in Somatotropinomas than Ki-67 and p53

(2010) Leandro Kasuki Jomori de Pinho et al.   NEUROENDOCRINOLOGY

Role of the addition of cabergoline to the management of acromegalic patients resistant to longterm treatment with octreotide LAR

(2010) Lucio Vilar et al.   Pituitary

Pituitary somatostatin receptor signaling

(2010) Anat Ben-Shlomo et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Somatostatin receptors subtypes 2 and 5, dopamine receptor type 2 expression and gsp status as predictors of octreotide LAR® responsiveness in acromegaly

(2009) Leonardo Vieira Neto et al.   Arquivos Brasileiros de Endocrinologia e Metabologia

QPCR: Application for real-time PCR data management and analysis

(2009) Stephan Pabinger et al.   BMC BIOINFORMATICS

Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications

(2009) Marie-Lise Jaffrain-Rea et al.   ENDOCRINE-RELATED CANCER

Identification and Characterization of Two Novel Truncated but Functional Isoforms of the Somatostatin Receptor Subtype 5 Differentially Present in Pituitary Tumors

(2009) Mario Durán-Prado et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Management of acromegaly in Latin America: expert panel recommendations

(2009) Ariel Barkan et al.   Pituitary

Octreotide LARvs.surgery in newly diagnosed patients with acromegaly: a randomized, open-label, multicentre study

(2008) Annamaria Colao et al.   CLINICAL ENDOCRINOLOGY

Quantitative analysis of somatostatin receptor subtypes (1–5) gene expression levels in somatotropinomas and correlation to in vivo hormonal and tumor volume responses to treatment with octreotide LAR

(2008) Giselle F Taboada et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Correlation ofin Vitroandin VivoSomatotropic Adenoma Responsiveness to Somatostatin Analogs and Dopamine Agonists with Immunohistochemical Evaluation of Somatostatin and Dopamine Receptors and Electron Microscopy

(2008) Diego Ferone et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Role of the Aryl Hydrocarbon Receptor-Interacting Protein Gene in Familial and Sporadic Pituitary Adenomas

(2008) Chrysanthia A. Leontiou et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM